46
1. personalized medicine means a probability culture.

International Biobanking Symposium IV - on consent in mobile studies

Embed Size (px)

Citation preview

1. personalized medicine

means a probability culture.

“predictions are hard. especially about the

future”

but predictions about me are increasingly

accurate.

“it’s like they know me”

it’s like they know me

probability is going to be a way that we make

personalized health happen.

requires a massive increase in sample size from today.

“Investigators will meet annually in-person with each participant to assess and record progression … every six months, the team

will conduct phone and mail surveys regarding diagnosis, medications, and

other impacts of the disease…”

689,003 people

active patients feel the system is failing them,

and are looking elsewhere.

“nothing about me without me!”

http://files.snpedia.com/reports/promethease_data/genome_jtw_ui2.html

2.

informed consent for studies at internet scale.

from 1800 to 100,000

1. series of interviews and requirements gathering

2. interaction design process and prototyping

3. consent development

courtesy of: David Fore

gait balance voice tapping

1. tiered information access by participants

2. “pictorial” dominant on first information tier

3. text dominant on second information tier

4. require perfect score on short assessment

34

64,926 enrolled since 9 March

(across 5 study apps using the method)

changeable by participant

70% choose to share broadly.

3.

it’s a method, not a product.

iconographic representations of key concepts in informed consent

“nouns and verbs”

http://sagebase.org/pcc

“sentences”

“separating your identity from your data”

design layouts

workflows

web templates and assets

2015 tasks:

- multi-stakeholder data sharing process development - new modules for e-consent - connection with biobanks

consent isn’t standalone. it connects to ethics and governance structures inside data use - and back.

thank you

http://sagebase.org/

@sagebio

@wilbanks